Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-02-24 @ 10:51 AM
Study NCT ID:
NCT00570635
Status:
COMPLETED
Last Update Posted:
2013-06-07
First Post:
2007-12-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
Sponsor:
Exelixis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XL820-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None